May 13, 2020: Prodrome Sciences is continuing operations during COVID-19. Our top priority is the safety and well-being of our employees, suppliers, and customers.

Dr. Goodenowe presents pancreatic cancer test

November 10, 2019

Dr. Goodenowe presents to over 500 gastroenterologists at seminar in Japan

We would like to thank the organizers of the 35th Annual Educational Seminar of the Japan Gastroenterology Study for the invitation for Dr. Goodenowe, Prodrome Sciences' Founder and CEO, to speak to the over 500 gastroenterologists that attended the seminar. Dr. Goodenowe presented more information our blood test, Prodrome-PAC, for the identification of persons with high pancreatic cancer risk. Prodrome Sciences and NK Medico (Japan) are pleased with and appreciate the growing support for Prodrome-PAC throughout Japan. 

Contact us for more information.

Keep in touch

©2021 Prodrome Sciences Inc.